Percutaneous Gastric Embolisation in Obese Patients: A Prospective Study of Mid-Term Outcomes
Authors:
- Carlos Ivan Soledispa SuárezCSCarlos Ivan Soledispa Suárez
- Robert Alarcón CedeñoRCRobert Alarcón Cedeño
- Luis Mariano de la Torre FonsecaLFLuis Mariano de la Torre Fonseca
- Stephanie Susana Alberca BonillaSBStephanie Susana Alberca Bonilla
- Fabiola Loor CedeñoFCFabiola Loor Cedeño
- Mayra Elizabeth Briones FajardoMFMayra Elizabeth Briones Fajardo
- Pablo Juan SalvadoresPSPablo Juan Salvadores
Preprint
- 5 March 2024
- preprint
- Published by Springer Nature in Research Square
Abstract
Introduction Obesity represents one of the most pressing public health challenges that needs to be solved globally, with serious health implications. Percutaneous gastric embolisation has emerged as a promising technique in the management of obesity. Objective This study aims to evaluate the relationship between endovascular procedure and weight loss in obese patients. In addition, to determine the complications related to percutaneous gastric embolisation in these patients. Design: Prospective longitudinal cohort study during the period from 1 January to 31 December 2022 and received treatment with percutaneous gastric embolisation Setting: This study includes patients admitted to the Haemodynamics Service of the Cardiovascular Health Institute during the year 2022. Participants: This study includes 15 patients diagnosed with grade III obesity who met the following criteria: patients ≥ 18 years with a diagnosis of obesity as determined by a body mass index greater than 30 kg/m2 and less than 40 kg/m 2, admitted between January to December 2022, and patients with a diagnosis of obesity with BMI > 40 kg/m2 with contraindication or refusal of bariatric. Main Outcome(s) and Measure(s): This is one of the largest studies in percutaneous gastric embolisation an obese population, while assessing the sustainability of weight loss outcomes. The main findings of the study can be summarised as follows: a) The procedure is safe without major complications, ulcers or gastric ischaemia, b) These technique achieves significant weight loss that is maintained over time. Results 86.7% were successful. Treated patients experienced significant weight loss when comparing baseline weight (101.2 ± 23.0 SE = 5.9) with weight at 6 months after the interventional procedure (91.5 ± 19.8, SE = 5.1) t(14) = 5.3, p < 0.001, d = 0.45. Especially males (106.7 ± 18.4, p = 0.01). No major vascular complications, gastric ulcer or ischaemia, or abdominal symptoms were documented in any of the patients included in the study. Only 6 patients (40%) presented with epigastralgia, 9 (60%) with nausea and 3 (20%) with vomiting. Conclusions Percutaneous gastric embolisation is an effective and safe procedure to reduce body mass index with a high success rate, well tolerated by obese patients, without major complications, whose results are maintained over time.Keywords
All Related Versions
This publication has 28 references indexed in Scilit:
- Left gastric artery embolization for obesity treatment: a systematic review and meta-analysis of human and animal studiesAbdominal Radiology, 2021
- Bariatric Embolization in the Treatment of Patients with a Body Mass Index Between 30 and 39.9 kg/m2 (Obesity Class I and II) and Metabolic Syndrome, a Pilot StudyCardioVascular and Interventional Radiology, 2021
- Transcatheter Bariatric Embolotherapy for Weight Reduction in ObesityJACC, 2020
- Physical activity, obesity and sedentary behavior in cancer etiology: epidemiologic evidence and biologic mechanismsMolecular Oncology, 2020
- Transradial left gastric artery embolization to treat severe obesity: A pilot studyCatheterization and Cardiovascular Interventions, 2018
- Bariatric Arterial Embolization for Obesity: A Review of Early Clinical EvidenceCardioVascular and Interventional Radiology, 2018
- Bariatric Embolization of the Left Gastric Arteries for the Treatment of Obesity: 9-Month Data in 5 PatientsObesity Surgery, 2017
- Proposal of a New Adverse Event Classification by the Society of Interventional Radiology Standards of Practice CommitteeJournal of Vascular and Interventional Radiology, 2017
- Gastric Artery Embolization Trial for the Lessening of Appetite Nonsurgically (GET LEAN): Six-Month Preliminary DataJournal of Vascular and Interventional Radiology, 2016
- Endovascular BariatricsJACC: Cardiovascular Interventions, 2015